T1	Participants 108 157	patients with acute respiratory distress syndrome
T2	Participants 163 220	patients with acute respiratory distress syndrome (ARDS),
T3	Participants 626 645	patients with ARDS.
T4	Participants 801 823	12 patients with ARDS,